Abstract | PURPOSE: The aim of this study was to give an overview of the prevalence of contact allergy to active ingredients and excipients of topical medications across Europe. METHODS: Retrospective analysis of data collected by the European Surveillance System on Contact Allergies (www.essca-dc.org) with substances applied to consecutively patch tested patients, 2009-2012, in 54 departments in 12 European countries. RESULTS: CONCLUSIONS: Several of the substances warrant routine screening for contact allergy, i.e. patch testing in a baseline series. However, in view of a vast number of other topical agents, additional patch testing with the suspect topical drug preparations (including natural remedies and cosmetics) is warranted. In the event of a positive test to the ( pharmaceutical) product, single ingredients should be tested individually to precisely identify the hapten(s). Copyright © 2016 John Wiley & Sons, Ltd.
|
Authors | Wolfgang Uter, Radoslaw Spiewak, Susan M Cooper, Mark Wilkinson, Javier Sánchez Pérez, Axel Schnuch, Marie-Louise Schuttelaar |
Journal | Pharmacoepidemiology and drug safety
(Pharmacoepidemiol Drug Saf)
Vol. 25
Issue 11
Pg. 1305-1312
(11 2016)
ISSN: 1099-1557 [Electronic] England |
PMID | 27464585
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 John Wiley & Sons, Ltd. |
Chemical References |
- Allergens
- Excipients
- Pharmaceutical Preparations
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Aged
- Allergens
(adverse effects)
- Child
- Child, Preschool
- Dermatitis, Allergic Contact
(epidemiology, etiology)
- Drug-Related Side Effects and Adverse Reactions
(epidemiology)
- Europe
(epidemiology)
- Excipients
(administration & dosage, adverse effects)
- Female
- Humans
- Male
- Middle Aged
- Patch Tests
- Pharmaceutical Preparations
(administration & dosage)
- Prevalence
- Retrospective Studies
- Young Adult
|